Our study demonstrated that DLX4 isoforms BP1 and DLX7 have opposite functions in leukemogenesis, with BP1 playing an oncogenic role whereas DLX7 plays a tumor suppressive role in leukemogenesis. The gene discussed is DLX4; the disease is neoplasm.